Published in AIDS Weekly, February 16th, 1998
Results from the multicenter study were presented at the Fifth Conference on Retroviruses and Opportunistic Infections, held in Chicago, Illinois, during February 1998.
Pablo Tebas, M.D., Washington University in St. Louis, Missouri, reported an evaluation of 26 patients from key clinical trials of VIRACEPT (studies 506 and 511) who had received VIRACEPT for an average of 55 weeks prior to experiencing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.